Lp(a) primarily binds to mature PCSK9 rather than furin-cleaved PCSK9, and evolocumab increases the mature form of PCSK-9 while halting the increase in plasma Lp(a) after acute myocardial infarction (MI) [78]. This evidence concerns the gene PCSK9 and myocardial infarction.